ZOSTAVAX® is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in
individuals 50 years of age and older.
Limitations of Use of ZOSTAVAX:
ZOSTAVAX is not indicated for the treatment of zoster or postherpetic neuralgia (PHN).
ZOSTAVAX is not indicated for prevention of primary varicella infection (Chickenpox).
